Filing Details

Accession Number:
0001209191-21-014690
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-26 16:07:07
Reporting Period:
2021-02-24
Accepted Time:
2021-02-26 16:07:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1557290 A Stuart Arbuckle C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp, Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-24 2,898 $217.57 44,737 No 4 F Direct
Common Stock Disposition 2021-02-25 380 $211.39 44,357 No 4 S Direct
Common Stock Disposition 2021-02-25 900 $212.52 43,457 No 4 S Direct
Common Stock Disposition 2021-02-25 1,400 $213.55 42,057 No 4 S Direct
Common Stock Disposition 2021-02-25 400 $214.32 41,657 No 4 S Direct
Common Stock Disposition 2021-02-25 300 $215.62 41,357 No 4 S Direct
Common Stock Disposition 2021-02-25 254 $216.57 41,103 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 140 Indirect 401(k)
Footnotes
  1. Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $211.39 (range $210.76 to $211.68).
  3. Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $212.52 (range $212.05 to $213.02).
  5. Open market sales reported on this line occurred at a weighted average price of $213.55 (range $213.09 to $214.08).
  6. Open market sales reported on this line occurred at a weighted average price of $214.32 (range $214.10 to $214.62).
  7. Open market sales reported on this line occurred at a weighted average price of $215.62 (range $215.37 to $215.84).
  8. Open market sales reported on this line occurred at a weighted average price of $216.57 (range $216.50 to $216.62).